291 related articles for article (PubMed ID: 34273716)
1. Phosphorescent rhenium(I) complexes conjugated with artesunate: Mitochondrial targeting and apoptosis-ferroptosis dual induction.
Ye RR; Chen BC; Lu JJ; Ma XR; Li RT
J Inorg Biochem; 2021 Oct; 223():111537. PubMed ID: 34273716
[TBL] [Abstract][Full Text] [Related]
2. Synthesis, characterization and antitumor mechanism investigation of ruthenium(II) polypyridyl complexes with artesunate moiety.
Chen BC; Lu JJ; Jiang N; Ma XR; Li RT; Ye RR
J Biol Inorg Chem; 2021 Dec; 26(8):909-918. PubMed ID: 34545414
[TBL] [Abstract][Full Text] [Related]
3. Artesunate induces ferroptosis via modulation of p38 and ERK signaling pathway in glioblastoma cells.
Song Q; Peng S; Che F; Zhu X
J Pharmacol Sci; 2022 Mar; 148(3):300-306. PubMed ID: 35177209
[TBL] [Abstract][Full Text] [Related]
4. Mitochondria-Accumulating Rhenium(I) Tricarbonyl Complexes Induce Cell Death via Irreversible Oxidative Stress and Glutathione Metabolism Disturbance.
Wang FX; Liang JH; Zhang H; Wang ZH; Wan Q; Tan CP; Ji LN; Mao ZW
ACS Appl Mater Interfaces; 2019 Apr; 11(14):13123-13133. PubMed ID: 30888144
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and mitochondria-localized iridium (III) complexes induce cell death through pyroptosis and ferroptosis pathways.
Hu H; Zhang F; Sheng Z; Tian S; Li G; Tang S; Niu Y; Yang J; Liu Y
Eur J Med Chem; 2024 Mar; 268():116295. PubMed ID: 38437750
[TBL] [Abstract][Full Text] [Related]
6. Emissive behavior, cytotoxic activity, cellular uptake, and PEGylation properties of new luminescent rhenium(I) polypyridine poly(ethylene glycol) complexes.
Choi AW; Louie MW; Li SP; Liu HW; Chan BT; Lam TC; Lin AC; Cheng SH; Lo KK
Inorg Chem; 2012 Dec; 51(24):13289-302. PubMed ID: 23198846
[TBL] [Abstract][Full Text] [Related]
7. Mitochondria-targeted Re(I) complexes bearing guanidinium as ligands and their anticancer activity.
He SF; Pan NL; Chen BB; Liao JX; Huang MY; Qiu HJ; Jiang DC; Wang JJ; Chen JX; Sun J
J Biol Inorg Chem; 2020 Dec; 25(8):1107-1116. PubMed ID: 33079244
[TBL] [Abstract][Full Text] [Related]
8. Ferroptosis Photoinduced by New Cyclometalated Iridium(III) Complexes and Its Synergism with Apoptosis in Tumor Cell Inhibition.
Yuan H; Han Z; Chen Y; Qi F; Fang H; Guo Z; Zhang S; He W
Angew Chem Int Ed Engl; 2021 Apr; 60(15):8174-8181. PubMed ID: 33656228
[TBL] [Abstract][Full Text] [Related]
9. Dinuclear phosphorescent rhenium(I) complexes as potential anticancer and photodynamic therapy agents.
Pan ZY; Cai DH; He L
Dalton Trans; 2020 Aug; 49(33):11583-11590. PubMed ID: 32766642
[TBL] [Abstract][Full Text] [Related]
10. Asymmetric silicon phthalocyanine based nanoparticle with spatiotemporally targeting of mitochondria for synergistic apoptosis-ferroptosis antitumor treatment.
Huang Y; Liu G; Zheng F; Chen J; Lin Y; Wang J; Huang Y; Peng Y
Colloids Surf B Biointerfaces; 2024 Jun; 238():113890. PubMed ID: 38608462
[TBL] [Abstract][Full Text] [Related]
11. Mitochondria-targeted iridium(III) complexes encapsulated in liposome induce cell death through ferroptosis and gasdermin-mediated pyroptosis.
Huang C; Yuan Y; Li G; Tian S; Hu H; Chen J; Liang L; Wang Y; Liu Y
Eur J Med Chem; 2024 Feb; 265():116112. PubMed ID: 38183779
[TBL] [Abstract][Full Text] [Related]
12. Artesunate synergistically promotes sorafenib‑induced apoptosis and ferroptosis in non‑Hodgkin lymphoma cells through inhibition of the STAT3 pathway.
Chen Y; Tao H; Wang F; Wu P; Gao J; Zhang X; He Z; Zhou Z; Jia Y
Oncol Rep; 2023 Jul; 50(1):. PubMed ID: 37326033
[TBL] [Abstract][Full Text] [Related]
13. Mitochondria-targeted phosphorescent cyclometalated iridium(III) complexes: synthesis, characterization, and anticancer properties.
Li Y; Liu B; Xu CX; He L; Wan YC; Ji LN; Mao ZW
J Biol Inorg Chem; 2020 Jun; 25(4):597-607. PubMed ID: 32232583
[TBL] [Abstract][Full Text] [Related]
14. Exploring the cytotoxic activity of new phenanthroline salicylaldimine Zn(II) complexes.
Matos CP; Addis Y; Nunes P; Barroso S; Alho I; Martins M; Matos APA; Marques F; Cavaco I; Costa Pessoa J; Correia I
J Inorg Biochem; 2019 Sep; 198():110727. PubMed ID: 31195153
[TBL] [Abstract][Full Text] [Related]
15. Artesunate synergizes with sorafenib to induce ferroptosis in hepatocellular carcinoma.
Li ZJ; Dai HQ; Huang XW; Feng J; Deng JH; Wang ZX; Yang XM; Liu YJ; Wu Y; Chen PH; Shi H; Wang JG; Zhou J; Lu GD
Acta Pharmacol Sin; 2021 Feb; 42(2):301-310. PubMed ID: 32699265
[TBL] [Abstract][Full Text] [Related]
16. Anticancer effect evaluation in vitro and in vivo of iridium(III) polypyridyl complexes targeting DNA and mitochondria.
Zhang H; Tian L; Xiao R; Zhou Y; Zhang Y; Hao J; Liu Y; Wang J
Bioorg Chem; 2021 Oct; 115():105290. PubMed ID: 34426145
[TBL] [Abstract][Full Text] [Related]
17. Neutral rhenium(I) tricarbonyl complexes with sulfur-donor ligands: anti-proliferative activity and cellular localization.
Levina A; Wardhani K; Stephens LJ; Werrett MV; Caporale C; Dallerba E; Blair VL; Massi M; Lay PA; Andrews PC
Dalton Trans; 2024 May; 53(18):7866-7879. PubMed ID: 38632950
[TBL] [Abstract][Full Text] [Related]
18. Simultaneously Inducing and Tracking Cancer Cell Metabolism Repression by Mitochondria-Immobilized Rhenium(I) Complex.
Yang J; Zhao JX; Cao Q; Hao L; Zhou D; Gan Z; Ji LN; Mao ZW
ACS Appl Mater Interfaces; 2017 Apr; 9(16):13900-13912. PubMed ID: 28368110
[TBL] [Abstract][Full Text] [Related]
19. Artesunate induces ferroptosis by inhibiting the nuclear localization of SREBP2 in myeloma cells.
Liang L; Liu Y; Wu X; Chen Y
Int J Med Sci; 2023; 20(12):1535-1550. PubMed ID: 37859702
[No Abstract] [Full Text] [Related]
20. Nrf2 inhibition reverses the resistance of cisplatin-resistant head and neck cancer cells to artesunate-induced ferroptosis.
Roh JL; Kim EH; Jang H; Shin D
Redox Biol; 2017 Apr; 11():254-262. PubMed ID: 28012440
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
